Pharmalicensing.com: Industry news http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: Industry news http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 CYTOMEDIX RETAINS DR. DAVID F. COUNTS, INVENTOR OF COMPANY'S ANTI-INFLAMMATORY PEPTIDE PATENT Rockville, MD, July 28, 2008 - Cytomedix, Inc. (AMEX: GTF), today announced that David F. Counts Ph.D., a leading pharmacologist and medical researcher who discovered the Company's anti-inflammatory... http://pharmalicensing.com/redirs/news_rss//public/news/view/432974/5 http://pharmalicensing.com/redirs/news_rss//public/news/view/432974/5 ST Receives Allowance from US Patent London - 31 July 2008 - Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announced that the United States Patent and Trademark Office has allowed the... http://pharmalicensing.com/redirs/news_rss//public/news/view/433302/5 http://pharmalicensing.com/redirs/news_rss//public/news/view/433302/5 WACKER and RFS Pharma Announce Assignment Agreement for an Improved Synthetic Process to Manufacture Amdoxovir Atlanta, GA / Munich, Germany, Aug 13, 2008 -Wacker Chemie AG and RFS Pharma, LLC, announce today a successful assignment on patent applications relating to a proprietary synthesis pathway for the... http://pharmalicensing.com/redirs/news_rss//public/news/view/435593/5 http://pharmalicensing.com/redirs/news_rss//public/news/view/435593/5 Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates MURRAY HILL, N.J., Jul 30, 2008 -- C. R. Bard, Inc. (NYSE: BCR) today announced that a U.S. District Court in Arizona entered judgment in Bard's favor in its patent infringement suit against W. L.... http://pharmalicensing.com/redirs/news_rss//public/news/view/433271/5 http://pharmalicensing.com/redirs/news_rss//public/news/view/433271/5 Pain Therapeutics and King Pharmaceuticals Announce Final Data of Remoxy Phase III Study at World Pain Congress in Scotland GLASGOW, SCOTLAND - August 19, 2008 - Pain Therapeutics, Inc. (NASDAQ: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) today presented the final data set of a previously announced pivotal Phase III... http://pharmalicensing.com/redirs/news_rss//public/news/view/436048/5 http://pharmalicensing.com/redirs/news_rss//public/news/view/436048/5